Tezepelumab Phase 1 PK study in healthy Chinese subjects

Trial Identifier:	D5180C00020
Sponsor:	AstraZeneca
Collaborator:	Amgen
NCTID::	NCT04362410
Start Date:	May 2020
Primary Completion Date:	October 2020
Study Completion Date:	October 2020
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Simplified Chinese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
China	Nanchang, China, 330006

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.